| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -27.70M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TPST returned -89.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -63.8% |
| 1 year | -89.6% |
| 5 years | -99.4% |
| 10 years | -100.0% |
| All-time high | $133,116.75 (Feb 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TPST would be worth today ›No. Tempest Therapeutics, Inc. has not paid a dividend in the past 12 months.
Tempest Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TPST.
Tempest Therapeutics, Inc. is part of the Healthcare sector.
Tempest Therapeutics, Inc. has a market cap of 16.62M USD, based on the latest quote.
Tempest Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
